Portfolio company
Somalogic
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company provides proteomic analysis services and protein measurement platforms to academic medical centres, pharmaceutical companies and biotechnology organisations for life sciences research.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Proteomics
This company develops automated benchtop instruments for multiplexed protein analysis to assist researchers in the biotechnology and pharmaceutical industries.
Nplex Biosciences
This company develops high-throughput proteomics platforms for researchers in pharmaceutical and academic sectors to measure proteins for drug and biomarker discovery.
Range Biotechnologies
This company develops a proteomics platform for high-throughput protein quantification to support pharmaceutical companies and clinical laboratories with drug discovery and diagnostics.
Alamar Biosciences
This company develops high-sensitivity proteomics platforms and protein biomarker detection assays for life sciences researchers and clinicians in drug development and disease research.
Single Cell Discoveries
This company provides single-cell sequencing and spatial transcriptomics services to pharmaceutical, biotechnology and academic organisations to support drug discovery and biological research.
Metabolon
This company develops metabolomics profiling kits and analysis services for pharmaceutical, biotechnology, and academic researchers to identify biomarkers and understand biological pathways.
Glyphic Biotechnologies
This company develops a single-molecule protein sequencing platform for researchers and institutions focused on biological research and drug discovery.
BigOmics Analytics
This company develops self-service software platforms for bioinformaticians and biologists to analyse and visualise transcriptomics and proteomics data within life science organisations.
